Abba Medix Group Releases Letter to Shareholders
(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 07/28/15 -- Abba Medix Group Inc. (CSE: ABA), released the following open letter to shareholders today:
Dear Shareholders,
I want to personally thank you for your investment in Abba Medix Group Inc. Since becoming a reporting issuer in March 2015, Abba has been very active in fulfilling its plan to be one of the clear market leaders in the fast-growing medical marijuana industry. It is Abba''s vision to become a fully integrated medical cannabis producer, in all its forms, as an authorized reseller and direct to patients under the Marihuana for Medical Purposes Regulations (MMPR).
In the last quarter Abba Medix has taken several bold steps to demonstrate its commitment and dedication to building the company''s brand into one of the category''s leaders. Here are the highlights:
Blow Vapor manufactures, markets, and distributes electronic cigarettes, e-liquids, and vaporizers. Abba has been working on the vaporizer technology with Blow Vapor. The liquid delivery system is ready to go with work being done on dosage metering capacity. Abba is committed to offering a premium and preferred method of marijuana delivery system in oil form. Abba will be ready to ship promptly after receiving Health Canada''s approval on the RedeCan facility.
As mentioned previously, this opens the door to non-smoking alternatives for the delivery of medical marijuana''s benefits for Canadians. Abba is delighted that Canadians registered to receive medical marijuana will be allowed to choose how to take their medicine including products such as cannabis-infused oils, capsules and vaporizers.
In other important developments, Abba Medix:
On behalf of the company and the Board of Directors, we thank our shareholders for all their support and confidence in us. We look forward to making further announcements and sharing them with you in the near future.
With best wishes,
Ahmad (Ray) Rasouli, President and CEO
About Abba Medix Group
Abba Medix Group Inc. (CSE: ABA) is a purveyor of fine Canadian medical marijuana, accessories, events and news. The Company intends to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully-integrated, Canadian medical marijuana marketplace. Abba''s mission is to find and acquire strong marijuana related businesses, product companies, organizational event sponsorships, and research and development opportunities.
Upon completion of its acquisition of RedeCan, Abba will be a licensed medical marijuana grower and sales agent, authorized to supply Canadian patients.
For more information on Abba Medix Group Inc., please visit . For more information on RedeCan, visit and on Blow Vapor, visit .
Cautionary Statements Regarding Forward-Looking Information
Certain statements within this press release relating to the Company constitute "forward-looking statements, "within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and / or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are "forward-looking statements." Such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including production and / or sales of medical marijuana, quantities of future medical marijuana production, anticipated revenues in connection with such sales, the overall projected size of the market, completion and / or expansion of production facilities, and other information that is based on forecasts of future results, estimates of production not yet determinable, and other key management assumptions. Actual results may differ materially from those expressed or implied by such forward-looking statements and involve risk and uncertainties relating to the Company''s historical experience with regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in medical marijuana prices, actual operating performance of facilities, and other uninsured risks. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Abba Medix Group Inc.
Ahmad (Ray) Rasouli
Chief Executive Officer
(905) 492-9420
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.07.2015 - 05:30 Uhr
Sprache: Deutsch
News-ID 1374940
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
TORONTO, ONTARIO
Phone:
Kategorie:
Alternative
Anmerkungen:
Diese Pressemitteilung wurde bisher 137 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Abba Medix Group Releases Letter to Shareholders
"
steht unter der journalistisch-redaktionellen Verantwortung von
Abba Medix Group Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
